MARKET COMPOSITE
Drugstore Chains Stocks28-00-2024 20:00:00 PM
Price
$106.94
+ 1.55%
The list of companies include BIMI-BOQI International Medical Inc, CJJD-China Jo-Jo Drugstores Inc, CVS-CVS Health Corp, PETS-Petmed Express, Inc., RAD-Rite Aid Corp., WBA-Walgreens Boots Alliance Inc
* Latest intraday update before market close @ 19:45:44 PM 03/28/2024
Summary
:
Average return is up 0.9%
Median return is up 0.5%
3 out of 5 stocks are up (limited to those with intraday pricing feeds).
Top Movers
:
BIMI -10.9%PETS -0.4%CVS + 0.5%WBA + 3.7%YI + 11.9%

Aggregated price index with volume information

Summary:

  • Drugstore Chains stocks up 1.5% on average while median return up 0.4% in a day
  • Drugstore Chains stocks down 0.6% on average while median return down -0.8% in a week
  • Drugstore Chains stocks down 18.4% on average while median return down 5.1% in a month
  • When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.

Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.

Related Stocks
Ticker
1d
7d
30d
PE Ratio
PE/G
P/B (mrq)
P/S (ttm)
Earning Growth
MarketCap
Short %
Held By Institutions %
RSI
Price Pattern
Resist Support
Days Since Channel Change
Channel Slope (daily rate %)
YI14.9%
-4.9%
-16.5%
3.090.0855.2M15%
WBA3.2%
4.3%
2.5%
32.533.112.080.319%18.7B2%59%56-\144-0.1%
CVS0.4%
1.9%
6.1%
12.332.471.530.4011%100.4B1%79%69\/\-At resistance2180.0%
PETS-1.0%
0.8%
-5.1%
-16.051.794.612.12-3%101.3M39%84%38\288-0.3%
BIMI-9.7%
-8.7%
-58.0%
0.992.0118.8M0%6%33/-/Below support1020.5%
* P/E and MarketCap are refreshed daily using IEX Cloud service. P/B, P/S, PEG, growth, short%, HelbyInstitute are refreshed weekly using Yahoo feeds. For latest stock stats please visit Yahoo Finance.
* Price Patter: / is upward trend, \ is downward trend, - is sideway. Click on the ticker to go to stock page to see Bayesian Trend model plot of the time series.
* Channel and change points are derived from Bayesian Trend model, where the channel slope is the growth rate while change points are those the model partition the time series.
Detail Performance Summary
  • 1M winners are : Winners for past month are $CVS 6.1%, $WBA 2.5%
  • 1M losers are : Losers for past month are $YI -16.5%, $BIMI -58.0%
  • 1W winners are : Winners for past week are $WBA 4.3%, $CVS 1.9%
  • 1W losers are : Losers for past week are $YI -4.9%, $BIMI -8.7%
Pick two stocks to compare:

Correlation Analysis

Index correlation analysis

Correlation for the past month is 24.5%, for the past 3 months is 20.1%

In the past month for a 5 days rolling window, the highest corrrelation is 68.7%, the lowest correlation is -20.8%, the latest correlation is 20.7%

When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.

Among pairwise correlation, the highest correlation is 51.3% between CVS and PETS

The lowest correlation is 10.8% between BIMI and WBA

Stock news

    The company notches convincing beats on headline fundamentals in its second-quarter earnings report.

    The S&P 500 closed out the week with slight gains on Thursday, with the benchmark index notching its strongest first quarter in five years, as investors digested the latest batch of economic data while looking towards the next inflation reading. Each of the three main U.S. indexes recorded solid quarterly gains, led by a climb of 10.16% for the S&P 500, aided by optimism over artificial intelligence (AI) related stocks and expectations the U.S. Federal Reserve will begin to cut interest rates t...

    Like Amazon.com Inc (NASDAQ: AMZN), Walgreens Boots Alliance (NASDAQ: WBA) is going for its piece of the healthcare pie. With its fiscal second quarter report, it topped estimates, but lowered the higher end of its full-year adjusted earnings guidance in response to a challenging macroeconomy. The new CEO, Tim Wentworth, continues to navigate the company out of a rough spot by slashing costs and solidifying the leadership team, but the company's healthcare transformation took its toll on the bot

    The blue-chip Dow sat less than 1% away from breaching the 40,000 level for the first time. Home Depot slipped 0.57% after the home improvement retailer said it would buy building materials supplier SRS Distribution in an $18.25 billion deal in its largest acquisition.

    AMC Entertainment falls sharply after the movie-theater chain files to sell $250 million of stock, RH sees demand trends ‘accelerating’ throughout the fiscal year, and shares of Palantir are downgraded.

    AMC Entertainment falls sharply after the movie-theater chain files to sell $250 million of stock, RH sees demand trends ‘accelerating’ throughout the fiscal year, and shares of Palantir are downgraded.

    Despite beating analyst expectations on both revenue and earnings in its latest second quarter results, Walgreens Boots Alliance (WBA) narrowed its Adjusted EPS guidance for fiscal year 2024, citing a challenging retail environment. Walgreens CEO Tim Wentworth joins Yahoo Finance Live to shed light on the factors that prompted the decision. Wentworth emphasizes that the "real dynamic" is the strain faced by consumers under current economic conditions. He highlights that consumers are seeking val...

    Walgreens lost nearly $6 billion in its second quarter mainly due to a drop in value for the VillageMD clinic business it controls. Excluding that charge, the drugstore chain reported results Thursday that topped Wall Street expectations. Walgreens spent more than $5 billion a few years ago to acquire a majority stake in VillageMD and launch a plan to add hundreds of clinics to its stores and grow its ability to provide care.

    Walgreens Boots' (WBA) comparable pharmacy sales in the fiscal second quarter benefited from higher branded drug inflation and strong execution in pharmacy services.

    Walgreens Boots Alliance (WBA) posted its second report, revealing a quarterly revenue that beat expectations but a narrow outlook for 2024, citing difficult conditions within the retail environment. Jefferies Healthcare Services Equity Researcher Brian Tanquilut joins Yahoo Finance to discuss Walgreens' performance for the quarter and how it can mount a turnaround. Tanquilut lays out one of the big problems with Walgreens and their strategy to implement VillageMD clinics in stores: "The problem...